Abstract The 148 Isoleucine to Methionine protein variant (I148M) of patatin-like
phospholipase domain-containing 3 (PNPLA3), a protein is expressed in the liver and is …

Background Non-alcoholic fatty liver disease (NAFLD) is a common disorder that is known to
be the leading cause of chronic liver disease worldwide. This study aims to systematically …

Genome‐wide association studies identified single‐nucleotide polymorphisms (SNPs) that
are associated with increased hepatic fat or elevated liver enzymes, presumably reflecting …

Nonalcoholic fatty liver disease (NAFLD) is a burgeoning health problem of unknown
etiology that varies in prevalence among ancestry groups. To identify genetic variants …

A recent genome‐wide study revealed an association between variation in the PNPLA3
gene and liver fat content. In addition, the PNPLA3 single‐nucleotide polymorphism …

Inter-individual and inter-ethnic differences and difference in the severity and progression of
liver disease among patients with non-alcoholic fatty liver disease (NAFLD) and alcoholic …

The accumulation of excess fat in the liver (hepatic steatosis) in the absence of heavy
alcohol consumption causes nonalcoholic fatty liver disease (NAFLD), which has become a …

Recent genome-wide association studies have identified that variants in or near PNPLA3,
NCAN, GCKR, LYPLAL1, and TM6SF2 are significantly associated with non-alcoholic fatty …

Abstract Background and Aim We investigated the effects of PNPLA3 rs738409, TM6SF2
rs58542926, and MBOAT7‐TMC4 rs641738 variants on metabolic phenotypes and their …

ABSTRACT Background. Background. Nonalcoholic fatty liver disease (NAFLD)
encompasses: fatty liver (SS), steatohepatitis (NASH) with or without fibrosis and cirrhosis …